Multicolour Digital PCR for ctDNA detection in breast cancer Tuesday, June 12, 2018
8AM PDT | 11AM EDT | 4PM BST | 5PM CEST
If you’ve already registered, please click here to log in to the webcast.
During the past years, interest in the use of circulating tumour DNA (ctDNA) as a non-invasive cancer biomarker has grown rapidly. Improvements in the genomic and molecular methods employed for ctDNA analysis are expanding the range of its potential applications, both in research settings and as a tool with clinical utility for cancer management. Several studies have demonstrated the attainability of ctDNA analysis to monitor response to treatment, assess the emergence of drug resistance and quantify minimal residual disease. In order to drive the implementation of ctDNA in personalized oncology and in cancer research several challenges remain to be circumvented.
During this webcast the speaker will address:
Technical challenges for clinical utility of liquid biopsy
ctDNA as a biomarker in breast cancer
dPCR for the detection of mutations on ctDNA
Understanding Multicolour dPCR
This webcast has been produced on behalf of the sponsor who retains sole responsibility for content. About this content
Translational Senior Scientific Officer The Institute of Cancer Research, London View Biography